Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

Proteomic Identification of Plasma Biomarkers in Children and Adolescents with Recurrent Hodgkin Lymphoma.

Repetto O, Mussolin L, Elia C, Martina L, Bianchi M, Buffardi S, Sala A, Burnelli R, Mascarin M, De Re V.

J Cancer. 2018 Nov 24;9(24):4650-4658. doi: 10.7150/jca.27560. eCollection 2018.

2.

Precision Measurement of Cosmic-Ray Nitrogen and its Primary and Secondary Components with the Alpha Magnetic Spectrometer on the International Space Station.

Aguilar M, Ali Cavasonza L, Alpat B, Ambrosi G, Arruda L, Attig N, Aupetit S, Azzarello P, Bachlechner A, Barao F, Barrau A, Barrin L, Bartoloni A, Basara L, Başeğmez-du Pree S, Battarbee M, Battiston R, Becker U, Behlmann M, Beischer B, Berdugo J, Bertucci B, Bindel KF, Bindi V, de Boer W, Bollweg K, Bonnivard V, Borgia B, Boschini MJ, Bourquin M, Bueno EF, Burger J, Burger WJ, Cai XD, Capell M, Caroff S, Casaus J, Castellini G, Cervelli F, Chang YH, Chen AI, Chen GM, Chen HS, Chen Y, Cheng L, Chou HY, Choumilov E, Choutko V, Chung CH, Clark C, Clavero R, Coignet G, Consolandi C, Contin A, Corti C, Creus W, Crispoltoni M, Cui Z, Dadzie K, Dai YM, Datta A, Delgado C, Della Torre S, Demirköz MB, Derome L, Di Falco S, Dimiccoli F, Díaz C, von Doetinchem P, Dong F, Donnini F, Duranti M, Egorov A, Eline A, Eronen T, Feng J, Fiandrini E, Fisher P, Formato V, Galaktionov Y, Gallucci G, García-López RJ, Gargiulo C, Gast H, Gebauer I, Gervasi M, Ghelfi A, Giovacchini F, Gómez-Coral DM, Gong J, Goy C, Grabski V, Grandi D, Graziani M, Guo KH, Haino S, Han KC, He ZH, Heil M, Hsieh TH, Huang H, Huang ZC, Incagli M, Jia Y, Jinchi H, Kanishev K, Khiali B, Kirn T, Konak C, Kounina O, Kounine A, Koutsenko V, Kulemzin A, La Vacca G, Laudi E, Laurenti G, Lazzizzera I, Lebedev A, Lee HT, Lee SC, Leluc C, Li HS, Li JQ, Li Q, Li TX, Li ZH, Li ZY, Lin CH, Lipari P, Lippert T, Liu D, Liu H, Liu Z, Lordello VD, Lu SQ, Lu YS, Luebelsmeyer K, Luo F, Luo JZ, Lyu SS, Machate F, Mañá C, Marín J, Martin T, Martínez G, Masi N, Maurin D, Menchaca-Rocha A, Meng Q, Mikuni VM, Mo DC, Mott P, Mussolin L, Nelson T, Ni JQ, Nikonov N, Nozzoli F, Oliva A, Orcinha M, Palermo M, Palmonari F, Palomares C, Paniccia M, Pauluzzi M, Pensotti S, Perrina C, Phan HD, Picot-Clemente N, Pilo F, Plyaskin V, Pohl M, Poireau V, Quadrani L, Qi XM, Qin X, Qu ZY, Räihä T, Rancoita PG, Rapin D, Ricol JS, Rosier-Lees S, Rozhkov A, Rozza D, Sagdeev R, Schael S, Schmidt SM, Schulz von Dratzig A, Schwering G, Seo ES, Shan BS, Shi JY, Siedenburg T, Song JW, Tacconi M, Tang XW, Tang ZC, Tescaro D, Tian J, Ting SCC, Ting SM, Tomassetti N, Torsti J, Urban T, Vagelli V, Valente E, Valtonen E, Vázquez Acosta M, Vecchi M, Velasco M, Vialle JP, Wang LQ, Wang NH, Wang QL, Wang X, Wang XQ, Wang ZX, Wei CC, Wei J, Weng ZL, Whitman K, Wu H, Xiong RQ, Xu W, Yan Q, Yang M, Yang Y, Yi H, Yu YJ, Yu ZQ, Zannoni M, Zeissler S, Zhang C, Zhang F, Zhang J, Zhang JH, Zhang SW, Zhang Z, Zheng ZM, Zhuang HL, Zhukov V, Zichichi A, Zimmermann N, Zuccon P; AMS Collaboration.

Phys Rev Lett. 2018 Aug 3;121(5):051103. doi: 10.1103/PhysRevLett.121.051103.

PMID:
30118280
3.

Pre-clinical evaluation of second generation PIM inhibitors for the treatment of T-cell acute lymphoblastic leukemia and lymphoma.

De Smedt R, Peirs S, Morscio J, Matthijssens F, Roels J, Reunes L, Lintermans B, Goossens S, Lammens T, Van Roy N, Touzart A, Jenni S, Tsai YC, Lovisa F, Mussolin L, Serafin V, Van Nieuwerburgh F, Deforce D, Uyttebroeck A, Tousseyn T, Burkhardt B, Klapper W, De Moerloose B, Benoit Y, Macintyre E, Bourquin JP, Basso G, Accordi B, Bornhauser B, Meijerink J, Vandenberghe P, Van Vlierberghe P.

Haematologica. 2019 Jan;104(1):e17-e20. doi: 10.3324/haematol.2018.199257. Epub 2018 Aug 3. No abstract available.

4.

Small RNAs in Circulating Exosomes of Cancer Patients: A Minireview.

Bortoluzzi S, Lovisa F, Gaffo E, Mussolin L.

High Throughput. 2017 Oct 6;6(4). pii: E13. doi: 10.3390/ht6040013. Review.

5.

Clinical impact of miR-223 expression in pediatric T-Cell lymphoblastic lymphoma.

Pomari E, Lovisa F, Carraro E, Primerano S, D'Amore ESG, Bonvini P, Nigro LL, Vito R, Vinti L, Farruggia P, Pillon M, Basso G, Basso K, Mussolin L.

Oncotarget. 2017 Nov 11;8(64):107886-107898. doi: 10.18632/oncotarget.22386. eCollection 2017 Dec 8.

6.

HLA-G+3027 polymorphism is associated with tumor relapse in pediatric Hodgkin's lymphoma.

De Re V, Caggiari L, Mussolin L, d'Amore ES, Famengo B, De Zorzi M, Martina L, Elia C, Pillon M, Santoro N, Muggeo P, Buffardi S, Bianchi M, Sala A, Farruggia P, Vinti L, Carosella ED, Burnelli R, Mascarin M.

Oncotarget. 2017 Nov 18;8(62):105957-105970. doi: 10.18632/oncotarget.22515. eCollection 2017 Dec 1.

7.

Epitope mapping of spontaneous autoantibodies to anaplastic lymphoma kinase (ALK) in non-small cell lung cancer.

Awad MM, Mastini C, Blasco RB, Mologni L, Voena C, Mussolin L, Mach SL, Adeni AE, Lydon CA, Sholl LM, Jänne PA, Chiarle R.

Oncotarget. 2017 Sep 23;8(54):92265-92274. doi: 10.18632/oncotarget.21182. eCollection 2017 Nov 3.

8.

Primary mediastinal large B-cell lymphoma: Outcome of a series of pediatric patients treated with high-dose methotrexate and cytarabine plus anti-CD20.

Pillon M, Carraro E, Mussolin L, Conter V, Tondo A, Aricò M, Mura R, Sala A, Vinti L, Buffardi S, Pierani P, d'Amore ESG, Basso G.

Pediatr Blood Cancer. 2018 Feb;65(2). doi: 10.1002/pbc.26855. Epub 2017 Oct 19.

PMID:
29049862
9.

Course of anti-ALK antibody titres during chemotherapy in children with anaplastic large cell lymphoma.

Mussolin L, Pillon M, Zimmermann M, Carraro E, Basso G, Knoerr F, Woessmann W, Damm-Welk C.

Br J Haematol. 2018 Sep;182(5):733-735. doi: 10.1111/bjh.14864. Epub 2017 Aug 31. No abstract available.

PMID:
28857122
10.

Detection of prognostic factors in children and adolescents with Burkitt and Diffuse Large B-Cell Lymphoma treated with the AIEOP LNH-97 protocol.

Pillon M, Mussolin L, Carraro E, Conter V, Aricò M, Vinti L, Garaventa A, Piglione M, Buffardi S, Sala A, Santoro N, Lo Nigro L, Mura R, Tondo A, Casale F, Farruggia P, Pierani P, Cesaro S, d'Amore ES, Basso G.

Br J Haematol. 2016 Nov;175(3):467-475. doi: 10.1111/bjh.14240. Epub 2016 Jul 8.

PMID:
27392319
11.

NPM-ALK expression levels identify two distinct subtypes of paediatric anaplastic large cell lymphoma.

Pomari E, Basso G, Bresolin S, Pillon M, Carraro E, d'Amore ES, Viola G, Frasson C, Basso K, Bonvini P, Mussolin L.

Leukemia. 2017 Feb;31(2):498-501. doi: 10.1038/leu.2016.292. Epub 2016 Oct 24. No abstract available.

PMID:
27773932
12.

Paediatric non-Hodgkin lymphoma - perspectives in translational biology.

Shiramizu B, Mussolin L, Woessmann W, Klapper W.

Br J Haematol. 2016 May;173(4):617-24. doi: 10.1111/bjh.14009. Epub 2016 Mar 24. Review.

13.

Kinetics of Circulating Plasma Cell-Free DNA in Paediatric Classical Hodgkin Lymphoma.

Primerano S, Burnelli R, Carraro E, Pillon M, Elia C, Farruggia P, Sala A, Vinti L, Buffardi S, Basso G, Mascarin M, Mussolin L.

J Cancer. 2016 Jan 12;7(4):364-6. doi: 10.7150/jca.13593. eCollection 2016.

14.

Abrupt Relapse of ALK-Positive Lymphoma after Discontinuation of Crizotinib.

Gambacorti-Passerini C, Mussolin L, Brugieres L.

N Engl J Med. 2016 Jan 7;374(1):95-6. doi: 10.1056/NEJMc1511045. No abstract available.

PMID:
26736010
15.

Non-Hodgkin Lymphoma in Children and Adolescents: Progress Through Effective Collaboration, Current Knowledge, and Challenges Ahead.

Minard-Colin V, Brugières L, Reiter A, Cairo MS, Gross TG, Woessmann W, Burkhardt B, Sandlund JT, Williams D, Pillon M, Horibe K, Auperin A, Le Deley MC, Zimmerman M, Perkins SL, Raphael M, Lamant L, Klapper W, Mussolin L, Poirel HA, Macintyre E, Damm-Welk C, Rosolen A, Patte C.

J Clin Oncol. 2015 Sep 20;33(27):2963-74. doi: 10.1200/JCO.2014.59.5827. Epub 2015 Aug 24. Review.

16.

Detection and role of minimal disseminated disease in children with lymphoblastic lymphoma: The AIEOP experience.

Mussolin L, Buldini B, Lovisa F, Carraro E, Disarò S, Lo Nigro L, d'Amore ES, Pillon M, Basso G.

Pediatr Blood Cancer. 2015 Nov;62(11):1906-13. doi: 10.1002/pbc.25607. Epub 2015 Jun 24.

PMID:
26109265
17.

Non-Hodgkin lymphoma in children with an associated inherited condition: A retrospective analysis of the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP).

Aricò M, Mussolin L, Carraro E, Buffardi S, Santoro N, D'Angelo P, Lombardi A, Pierani P, Giraldi E, Mura R, Sala A, Garaventa A, Tondo A, Piglione M, Lo Nigro L, Cesaro S, Perruccio K, Rosolen A, Basso G, Pillon M; NHL-Committee of the Italian Association of Pediatric Hematology Oncology.

Pediatr Blood Cancer. 2015 Oct;62(10):1782-9. doi: 10.1002/pbc.25565. Epub 2015 May 22.

PMID:
26011068
18.

Prognostic factors in paediatric anaplastic large cell lymphoma: role of ALK.

Damm-Welk C, Pillon M, Woessmann W, Mussolin L.

Front Biosci (Schol Ed). 2015 Jun 1;7:205-16. Review.

PMID:
25961696
19.

ALK kinase domain mutations in primary anaplastic large cell lymphoma: consequences on NPM-ALK activity and sensitivity to tyrosine kinase inhibitors.

Lovisa F, Cozza G, Cristiani A, Cuzzolin A, Albiero A, Mussolin L, Pillon M, Moro S, Basso G, Rosolen A, Bonvini P.

PLoS One. 2015 Apr 13;10(4):e0121378. doi: 10.1371/journal.pone.0121378. eCollection 2015.

20.

Impact of persistent minimal residual disease post-consolidation therapy in children and adolescents with advanced Burkitt leukaemia: a Children's Oncology Group Pilot Study Report.

Shiramizu B, Goldman S, Smith L, Agsalda-Garcia M, Galardy P, Perkins SL, Frazer JK, Sanger W, Anderson JR, Gross TG, Weinstein H, Harrison L, Barth MJ, Mussolin L, Cairo MS.

Br J Haematol. 2015 Aug;170(3):367-71. doi: 10.1111/bjh.13443. Epub 2015 Apr 8.

21.

Long-term results of the AIEOP LNH-97 protocol for childhood lymphoblastic lymphoma.

Pillon M, Aricò M, Mussolin L, Carraro E, Conter V, Sala A, Buffardi S, Garaventa A, D'Angelo P, Lo Nigro L, Santoro N, Piglione M, Lombardi A, Porta F, Cesaro S, Moleti ML, Casale F, Mura R, d'Amore ES, Basso G, Rosolen A.

Pediatr Blood Cancer. 2015 Aug;62(8):1388-94. doi: 10.1002/pbc.25469. Epub 2015 Mar 8.

PMID:
25755200
22.

Mediastinal Burkitt lymphoma in childhood.

Pillon M, Aricò M, Mussolin L, Mainardi C, Giraldi E, Garaventa A, Lombardi A, Santoro N, Carraro E, d'Amore ES, Rosolen A; Italian Association of Pediatric Hematology, Oncology AIEOP Non-Hodgkin Lymphoma Working Group.

Pediatr Blood Cancer. 2014 Nov;61(11):2127-8. doi: 10.1002/pbc.25127. Epub 2014 Jul 22. No abstract available.

PMID:
25053233
23.

MicroRNA 28 controls cell proliferation and is down-regulated in B-cell lymphomas.

Schneider C, Setty M, Holmes AB, Maute RL, Leslie CS, Mussolin L, Rosolen A, Dalla-Favera R, Basso K.

Proc Natl Acad Sci U S A. 2014 Jun 3;111(22):8185-90. doi: 10.1073/pnas.1322466111. Epub 2014 May 19.

24.

An aberrant microRNA signature in childhood T-cell lymphoblastic lymphoma affecting CDKN1B expression, NOTCH1 and growth factor signaling pathways.

Mussolin L, Holmes AB, Romualdi C, Sales G, D'Amore ES, Ghisi M, Pillon M, Rosolen A, Basso K.

Leukemia. 2014 Sep;28(9):1909-12. doi: 10.1038/leu.2014.134. Epub 2014 Apr 14. No abstract available.

PMID:
24727675
25.

Crizotinib in advanced, chemoresistant anaplastic lymphoma kinase-positive lymphoma patients.

Gambacorti Passerini C, Farina F, Stasia A, Redaelli S, Ceccon M, Mologni L, Messa C, Guerra L, Giudici G, Sala E, Mussolin L, Deeren D, King MH, Steurer M, Ordemann R, Cohen AM, Grube M, Bernard L, Chiriano G, Antolini L, Piazza R.

J Natl Cancer Inst. 2014 Feb;106(2):djt378. doi: 10.1093/jnci/djt378.

PMID:
24491302
26.

Monoallelic mutations of the perforin gene may represent a predisposing factor to childhood anaplastic large cell lymphoma.

Ciambotti B, Mussolin L, d'Amore ES, Pillon M, Sieni E, Coniglio ML, Ros MD, Cetica V, Aricò M, Rosolen A.

J Pediatr Hematol Oncol. 2014 Aug;36(6):e359-65. doi: 10.1097/MPH.0000000000000073.

PMID:
24309606
27.

Early assessment of minimal residual disease identifies patients at very high relapse risk in NPM-ALK-positive anaplastic large-cell lymphoma.

Damm-Welk C, Mussolin L, Zimmermann M, Pillon M, Klapper W, Oschlies I, d'Amore ES, Reiter A, Woessmann W, Rosolen A.

Blood. 2014 Jan 16;123(3):334-7. doi: 10.1182/blood-2013-09-526202. Epub 2013 Dec 2.

28.

Plasma cell-free DNA in paediatric lymphomas.

Mussolin L, Burnelli R, Pillon M, Carraro E, Farruggia P, Todesco A, Mascarin M, Rosolen A.

J Cancer. 2013 Apr 16;4(4):323-9. doi: 10.7150/jca.6226. Print 2013.

29.

Use of minimal disseminated disease and immunity to NPM-ALK antigen to stratify ALK-positive ALCL patients with different prognosis.

Mussolin L, Damm-Welk C, Pillon M, Zimmermann M, Franceschetto G, Pulford K, Reiter A, Rosolen A, Woessmann W.

Leukemia. 2013 Feb;27(2):416-22. doi: 10.1038/leu.2012.205. Epub 2012 Jul 18.

PMID:
22907048
30.

Results of AIEOP LNH-97 protocol for the treatment of anaplastic large cell lymphoma of childhood.

Pillon M, Gregucci F, Lombardi A, Santoro N, Piglione M, Sala A, D'Amore ES, De Santis R, Casale F, Zecca M, Mussolin L, Rosolen A; NHL-Committee of the Italian Association of Pediatric Hematology and Oncology (AIEOP).

Pediatr Blood Cancer. 2012 Nov;59(5):828-33. doi: 10.1002/pbc.24125. Epub 2012 Mar 2.

PMID:
22389307
31.

Consequences of heat shock protein 72 (Hsp72) expression and activity on stress-induced apoptosis in CD30+ NPM-ALK+ anaplastic large-cell lymphomas.

Bonvini P, Zorzi E, Mussolin L, Pillon M, Romualdi C, Peron M, d'Amore ES, Lamant L, Rosolen A.

Leukemia. 2012 Jun;26(6):1375-82. doi: 10.1038/leu.2011.367. Epub 2012 Jan 6.

PMID:
22289917
32.

T-cell lymphoblastic lymphoma shows differences and similarities with T-cell acute lymphoblastic leukemia by genomic and gene expression analyses.

Basso K, Mussolin L, Lettieri A, Brahmachary M, Lim WK, Califano A, Basso G, Biondi A, Cazzaniga G, Rosolen A.

Genes Chromosomes Cancer. 2011 Dec;50(12):1063-75. doi: 10.1002/gcc.20924. Epub 2011 Aug 30.

PMID:
21987448
33.

Modulation of microRNA expression in human T-cell development: targeting of NOTCH3 by miR-150.

Ghisi M, Corradin A, Basso K, Frasson C, Serafin V, Mukherjee S, Mussolin L, Ruggero K, Bonanno L, Guffanti A, De Bellis G, Gerosa G, Stellin G, D'Agostino DM, Basso G, Bronte V, Indraccolo S, Amadori A, Zanovello P.

Blood. 2011 Jun 30;117(26):7053-62. doi: 10.1182/blood-2010-12-326629. Epub 2011 May 6.

34.

Minimal disseminated disease in high-risk Burkitt's lymphoma identifies patients with different prognosis.

Mussolin L, Pillon M, d'Amore ES, Conter V, Piglione M, Lo Nigro L, Garaventa A, Buffardi S, Aricò M, Rosolen A.

J Clin Oncol. 2011 May 1;29(13):1779-84. doi: 10.1200/JCO.2010.32.8161. Epub 2011 Mar 21. Erratum in: J Clin Oncol. 2015 Jun 10;33(17):1991.

PMID:
21422413
35.

Cytogenetic analysis of pediatric anaplastic large cell lymphoma.

Mussolin L, Pillon M, Bonato P, Leszl A, Franceschetto G, Di Meglio A, d'Amore ES, Sainati L, Rosolen A.

Pediatr Blood Cancer. 2010 Sep;55(3):446-51. doi: 10.1002/pbc.22550.

PMID:
20658615
36.

IGH and IGK gene rearrangements as PCR targets for pediatric Burkitt's lymphoma and mature B-ALL MRD analysis.

Lovisa F, Mussolin L, Corral L, Pillon M, Cazzaniga G, Biondi A, Rosolen A.

Lab Invest. 2009 Oct;89(10):1182-6. doi: 10.1038/labinvest.2009.81. Epub 2009 Aug 10.

37.

Long-term results of AIEOP LNH-92 protocol for the treatment of pediatric lymphoblastic lymphoma: a report of the Italian Association of Pediatric Hematology and Oncology.

Pillon M, Piglione M, Garaventa A, Conter V, Giuliano M, Arcamone G, Mura R, Cellini M, D'Amore ES, Varotto S, Mussolin L, Rosolen A; AIEOP-NHL Committee.

Pediatr Blood Cancer. 2009 Dec;53(6):953-9. doi: 10.1002/pbc.22162.

PMID:
19621432
38.

The effect of the cyclin-dependent kinase inhibitor flavopiridol on anaplastic large cell lymphoma cells and relationship with NPM-ALK kinase expression and activity.

Bonvini P, Zorzi E, Mussolin L, Monaco G, Pigazzi M, Basso G, Rosolen A.

Haematologica. 2009 Jul;94(7):944-55. doi: 10.3324/haematol.2008.004861. Epub 2009 Jun 16.

39.

Kinetics of humoral response to ALK and its relationship with minimal residual disease in pediatric ALCL.

Mussolin L, Bonvini P, Ait-Tahar K, Pillon M, Tridello G, Buffardi S, Lombardi A, Pulford K, Rosolen A.

Leukemia. 2009 Feb;23(2):400-2. doi: 10.1038/leu.2008.184. Epub 2008 Jul 10. No abstract available.

PMID:
18615104
40.

Prognostic role of minimal residual disease in mature B-cell acute lymphoblastic leukemia of childhood.

Mussolin L, Pillon M, Conter V, Piglione M, Lo Nigro L, Pierani P, Micalizzi C, Buffardi S, Basso G, Zanesco L, Rosolen A.

J Clin Oncol. 2007 Nov 20;25(33):5254-61.

PMID:
18024872
41.

Germline mutations of the perforin gene are a frequent occurrence in childhood anaplastic large cell lymphoma.

Cannella S, Santoro A, Bruno G, Pillon M, Mussolin L, Mangili G, Rosolen A, Aricò M.

Cancer. 2007 Jun 15;109(12):2566-71.

42.

ALK-positive plasmablastic B-cell lymphoma with the clathrin-ALK gene rearrangement.

Isimbaldi G, Bandiera L, d'Amore ES, Conter V, Milani M, Mussolin L, Rosolen A.

Pediatr Blood Cancer. 2006 Mar;46(3):390-1. No abstract available.

PMID:
16086416
43.

Prevalence and clinical implications of bone marrow involvement in pediatric anaplastic large cell lymphoma.

Mussolin L, Pillon M, d'Amore ES, Santoro N, Lombardi A, Fagioli F, Zanesco L, Rosolen A.

Leukemia. 2005 Sep;19(9):1643-7.

PMID:
16049513
44.

Prospective analysis of minimal bone marrow infiltration in pediatric Burkitt's lymphomas by long-distance polymerase chain reaction for t(8;14)(q24;q32).

Mussolin L, Basso K, Pillon M, D'Amore ES, Lombardi A, Luzzatto L, Zanesco L, Rosolen A.

Leukemia. 2003 Mar;17(3):585-9.

PMID:
12646948

Supplemental Content

Loading ...
Support Center